AbbVie Valuation

<div class='circular--portrait' style='background:#CD0D74;color: white;font-size:3em;padding-top: 40px;;'>ABB</div>
ABBV -- USA Stock  

Fiscal Quarter End: March 31, 2020  

Free Cash Flow is likely to grow to about 15.9 B in 2020, whereas Enterprise Value is likely to drop slightly above 157.1 B in 2020. AbbVie shows prevailing Real Value of $100.53 per share. The current price of the firm is $93.14. At this time the firm appears to be under valued. This module approximates value of AbbVie from analyzing the firm fundamentals such as Profit Margin of 0.001  and Return On Equity of (1.88)  as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor to go long with undervalued instruments and to trade away overvalued instruments since at some point assets prices and their ongoing real values will blend.
Under Valued
February 25, 2020
Real Value
AbbVie is very steady asset. Calculation of real value of AbbVie is based on 3 months time horizon. Increasing AbbVie time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.

AbbVie Valuation Drivers Correlation

Click cells to compare fundamentals   View All Correlations
AbbVie Valuation Data Drivers
Net Income Per Employee    Enterprise Value    Market Capitalization    

AbbVie Market Cap

AbbVie is rated fifth in market capitalization category among related companies. Market capitalization of Drug Manufacturers?General industry is presently estimated at about 1.71 Trillion. AbbVie holds roughly 137.35 Billion in market capitalization claiming about 8% of equities under Drug Manufacturers?General industry.
Capitalization  Total debt  Workforce  Revenue  Valuation
AbbVie is number one stock in last dividend paid category among related companies. It is rated third in price to earning category among related companies reporting about  8.98  of Price to Earning per Last Dividend Paid.

AbbVie Valuation Basics

AbbVie Enterprise Value Fundamentals

Revenue Growth4.80%
Payout Ratio81.06%
Enterprise Value To Ebitda10.55
Enterprise Value To Revenue5.03

AbbVie Valuation Indicators

AbbVie Valuation Fundamental Ratios

Please continue to Trending Equities. Please also try Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Company logos by clearbit